体外受精后个体化累积活产预测模型
基于SART全国数据88,614名使用自体卵子和伴侣精子的女性,开发了治疗前(预测最多三个完整周期的累积活产)和治疗后(预测第二和第三周期的累积活产)两个预测模型。治疗前预测因子包括女性年龄和BMI,治疗后模型额外纳入第一周期获卵数。模型C统计量在0.71-0.73之间,可帮助临床医生和夫妇在不同时间点规划IVF治疗。
要点
- 治疗前模型预测最多三个完整周期的累积活产,治疗后模型预测第二和第三周期的累积活产。
- 女性年龄35岁vs25岁调整OR 0.69(95%CI 0.66-0.73),BMI 35 vs 25 kg/m2调整OR 0.75(95%CI 0.72-0.78)。
- 治疗后模型额外纳入第一周期获卵数(15 vs 9个,调整OR 1.10,95%CI 1.03-1.18)。
核心结论
- 新型预测模型可提供临床相关估计,帮助临床医生和夫妇在不同时间点规划IVF治疗。
研究设计与样本
- 基于人群的队列研究,使用SART Clinic Outcome Reporting System全国数据,纳入88,614名开始IVF治疗并使用自体卵子和伴侣精子的女性。
主要发现
- 治疗前预测因子包括女性年龄和BMI;治疗后模型额外包括第一周期获卵数。
- 根据治疗前模型,一名34岁、BMI 23.3 kg/m2、男方因素不孕、AMH 3 ng/mL的未产女性,第一个完整周期活产概率61.7%,三个完整周期累积概率88.8%。
- 若未获活产,根据治疗后模型,1年后(35岁,获卵数7个)第二个完整周期活产概率42.9%。
- 所有模型C统计量在0.71-0.73之间。
临床怎么用
- 可在开始第一个完整周期前使用治疗前模型评估最多三个周期的累积活产概率。
- 在第一个周期未成功时,可使用治疗后模型评估后续周期的活产概率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop in vitro fertilization (IVF) prediction models to estimate the individualized chance of cumulative live birth at two time points: pretreatment (i.e., before starting the first complete cycle of IVF) and posttreatment (i.e., before starting the second complete cycle of IVF in those couples whose first complete cycle was unsuccessful). DESIGN: Population-based cohort study. SETTING: National data from the Society for Assisted Reproductive Technology (SART) Clinic Outcome Reporting System. PATIENT(S): Based on 88,614 women who commenced IVF treatment using their own eggs and partner's sperm in SART member clinics. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): The pretreatment model estimated the cumulative chance of a live birth over a maximum of three complete cycles of IVF, whereas the posttreatment model did so over the second and third complete cycles. One complete cycle included all fresh and frozen embryo transfers resulting from one episode of ovarian stimulation. We considered the first live birth episode, including singletons and multiple births. RESULT(S): Pretreatment predictors included woman's age (35 years vs. 25 years, adjusted odds ratio 0.69, 95% confidence interval 0.66-0.73) and body mass index (35 kg/m2 vs. 25 kg/m2, adjusted odds ratio 0.75, 95% confidence interval 0.72-0.78). The posttreatment model additionally included the number of eggs from the first complete cycle (15 vs. 9 eggs, adjusted odds ratio 1.10, 95% confidence interval 1.03-1.18). According to the pretreatment model, a nulliparous woman aged 34 years with a body mass index of 23.3 kg/m2, male partner infertility, and an antimüllerian hormone level of 3 ng/mL has a 61.7% chance of having a live birth over her first complete cycle of IVF (and a cumulative chance over three complete cycles of 88.8%). If a live birth is not achieved, according to the posttreatment model, her chance of having a live birth over the second complete cycle 1 year later (age 35 years, number of eggs 7) is 42.9%. The C-statistic for all models was between 0.71 and 0.73. CONCLUSION(S): The focus of previous IVF prediction models based on US data has been cumulative live birth excluding cycles involving frozen embryos. These novel prediction models provide clinically relevant estimates that could help clinicians and couples plan IVF treatment at different points in time.
引用
- McLernon DJ, Raja EA, Toner JP, et al. Predicting personalized cumulative live birth following in vitro fertilization. Fertil Steril. 2021. PMID: 34674824. doi:10.1016/j.fertnstert.2021.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。